| ■ 영문 제목 : Global mRNA Vaccines & Therapeutics Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02098 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 108 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 mRNA 백신 및 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (감염 백신, 암 백신)와 용도별 시장규모 (감염증, 암) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 mRNA 백신 및 치료제 시장 점유율 - 지역별 mRNA 백신 및 치료제 시장규모 - 주요지역의 종류별 시장규모 (감염 백신, 암 백신) - 주요지역의 용도별 시장규모 (감염증, 암) - 미주의 mRNA 백신 및 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 mRNA 백신 및 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 mRNA 백신 및 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 mRNA 백신 및 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 mRNA 백신 및 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology - 조사의 결과/결론 |
According to this latest study, the 2021 growth of mRNA Vaccines & Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Vaccines & Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ million in 2020. Over the next five years the mRNA Vaccines & Therapeutics market will register a 37.0% CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Infectious Disease Vaccines
Cancer Vaccines
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Infectious Disease
Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Scope of the Report 2 Executive Summary 3 Global mRNA Vaccines & Therapeutics by Company 4 mRNA Vaccines & Therapeutics by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global mRNA Vaccines & Therapeutics Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. mRNA Vaccines & Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Infectious Disease Vaccines Table 3. Major Players of Cancer Vaccines Table 4. Global mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 6. Global mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & ($ million) Table 7. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021) Table 8. Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021) Table 9. Global mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 10. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 11. Global mRNA Vaccines & Therapeutics Value by Application (2016-2021) Table 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021) Table 13. Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021) Table 14. Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021) & (M Doses) Table 15. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021) Table 16. Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021) ($ Millions) Table 17. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021) Table 18. Global mRNA Vaccines & Therapeutics Sale Price by Company (2019-2021) Table 19. Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution and Sales Area Table 20. Players mRNA Vaccines & Therapeutics Products Offered Table 21. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global mRNA Vaccines & Therapeutics Sales by Region (2016-2021) (M Doses) Table 25. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021) Table 26. Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 27. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021) Table 28. Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses) Table 29. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021) Table 30. Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021) Table 32. Americas mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 34. Americas mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 35. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 36. APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021) & (M Doses) Table 37. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021) Table 38. APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021) Table 40. APAC mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 42. APAC mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 43. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 44. Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses) Table 45. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021) Table 46. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021) Table 48. Europe mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 50. Europe mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses) Table 53. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of mRNA Vaccines & Therapeutics Table 61. Key Application and Potential Industries of mRNA Vaccines & Therapeutics Table 62. Key Challenges of mRNA Vaccines & Therapeutics Table 63. Key Trends of mRNA Vaccines & Therapeutics Table 64. mRNA Vaccines & Therapeutics Distributors List Table 65. mRNA Vaccines & Therapeutics Customer List Table 66. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2021-2026) & (M Doses) Table 67. Global mRNA Vaccines & Therapeutics Consumption Market Forecast by Region Table 68. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses) Table 71. Americas mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC mRNA Vaccines & Therapeutics Sales Forecast by Region (2021-2026) & (M Doses) Table 73. APAC mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses) Table 75. Europe mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses) Table 77. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026) & (M Doses) Table 79. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2021-2026) Table 80. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2021-2026) Table 82. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026) & (M Doses) Table 83. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2021-2026) Table 84. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2021-2026) Table 86. Moderna Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 87. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 88. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 89. Moderna Therapeutics Main Business Table 90. Moderna Therapeutics Latest Developments Table 91. CureVac Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 92. CureVac mRNA Vaccines & Therapeutics Product Offered Table 93. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 94. CureVac Main Business Table 95. CureVac Latest Developments Table 96. Translate Bio Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 97. Translate Bio mRNA Vaccines & Therapeutics Product Offered Table 98. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 99. Translate Bio Main Business Table 100. Translate Bio Latest Developments Table 101. BioNTech Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 102. BioNTech mRNA Vaccines & Therapeutics Product Offered Table 103. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 104. BioNTech Main Business Table 105. BioNTech Latest Developments Table 106. Sangamo Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 107. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 108. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 109. Sangamo Therapeutics Main Business Table 110. Sangamo Therapeutics Latest Developments Table 111. Argos Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 112. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 113. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 114. Argos Therapeutics Main Business Table 115. Argos Therapeutics Latest Developments Table 116. In-Cell-Art Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 117. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered Table 118. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 119. In-Cell-Art Main Business Table 120. In-Cell-Art Latest Developments Table 121. eTheRNA Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 122. eTheRNA mRNA Vaccines & Therapeutics Product Offered Table 123. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 124. eTheRNA Main Business Table 125. eTheRNA Latest Developments Table 126. Ethris Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 127. Ethris mRNA Vaccines & Therapeutics Product Offered Table 128. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 129. Ethris Main Business Table 130. Ethris Latest Developments Table 131. Tiba Biotechnology Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 132. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered Table 133. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 134. Tiba Biotechnology Main Business Table 135. Tiba Biotechnology Latest Developments List of Figures Figure 1. Picture of mRNA Vaccines & Therapeutics Figure 2. mRNA Vaccines & Therapeutics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global mRNA Vaccines & Therapeutics Sales Growth Rate 2016-2026 (M Doses) Figure 7. Global mRNA Vaccines & Therapeutics Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. mRNA Vaccines & Therapeutics Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Infectious Disease Vaccines Figure 10. Product Picture of Cancer Vaccines Figure 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021) Figure 13. mRNA Vaccines & Therapeutics Consumed in Infectious Disease Figure 14. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2016-2021) & (M Doses) Figure 15. mRNA Vaccines & Therapeutics Consumed in Cancer Figure 16. Global mRNA Vaccines & Therapeutics Market: Cancer (2016-2021) & (M Doses) Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2020 Figure 19. mRNA Vaccines & Therapeutics Revenue Market by Company in 2020 ($ Million) Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2020 Figure 21. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2016-2021) Figure 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2020 Figure 23. Americas mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 24. Americas mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 25. APAC mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 26. APAC mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 27. Europe mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 28. Europe mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 30. Middle East & Africa mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 31. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020 Figure 32. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020 Figure 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 34. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 35. United States mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region in 2020 Figure 40. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2020 Figure 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 42. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 43. China mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 47. India mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020 Figure 50. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020 Figure 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 52. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 53. Germany mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 54. France mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 55. UK mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020 Figure 59. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 61. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 62. Egypt mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 mRNA 백신 및 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02098) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 mRNA 백신 및 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |